查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1942759

2026年全球药物释放型球囊导管市场报告

Drug Eluting Balloons Catheters Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物释放型球囊导管市场发展迅速，预计将从2025年的16.5亿美元成长到2026年的18.6亿美元，复合年增长率达12.5%。过去几年的成长可归因于冠状动脉疾病盛行率的上升、经皮冠状动脉介入治疗（PCI）的日益普及、球囊导管材料的技术进步、紫杉醇涂层器械的临床应用以及介入性心臟病中心的扩张等因素。

预计未来几年，药物释放型球囊导管市场将快速成长，到2030年市场规模将达到29.2亿美元，复合年增长率（CAGR）为11.9%。预测期内的成长要素包括：对微创血管手术的需求不断增长、基于Sirolimus的球囊导管应用日益广泛、週边血管疾病治疗范围不断扩大、对下一代导管技术的投资不断增加，以及对患者长期预后的日益关注。预测期内的主要趋势包括：药物涂层球囊技术的应用日益普及，其在冠状动脉和周边血管介入治疗中的应用日益广泛，无支架治疗方法的偏好不断增强，先进药物涂层技术的推广应用，以及对预防血管再阻塞再狭窄的日益重视。

预计未来几年，週边血管疾病和心血管疾病的日益普遍将推动药物释放型球囊导管市场的成长。心血管疾病（CVD）涵盖多种影响心臟和循环系统的疾病，而周边动脉疾病（PAD）则特别指动脉狭窄，主要导致四肢血流减少。药物释放型球囊导管用于治疗冠状动脉疾病（CAD），它由涂有抗增殖剂的半顺应性血管成形术用气球组成，这些抗增殖剂在与血管壁接触时可防止血管再阻塞。例如，根据美国非营利组织美国心臟协会的数据，截至2024年1月，经年龄已调整的心血管疾病死亡率预计将上升至每10万人233.3例，比2023年的每10万人224.4例增加4.0%。因此，週边血管疾病和心血管疾病盛行率的上升正在推动药物释放型球囊导管市场的扩张。

为了确保竞争优势，药物释放型球囊导管市场的主要企业正致力于开发搭载先进技术的下一代产品。例如，2024年3月，总部位于美国的医疗设备和生技公司波士顿科学宣布，其AGENT药物涂层球囊（DCB）已获得美国食品药物管理局（FDA）的核准。本产品是美国首个用于治疗支架内血管再阻塞（ISR）的药物涂层冠状动脉球囊。支架内再狭窄是指支架植入后，斑块或疤痕组织阻塞血管。 AGENT DCB涂覆紫杉醇，可将治疗剂量的药物输送到血管壁，有效预防ISR復发，无需再次植入支架或接受放射治疗。临床试验证实，该产品可使标靶部位心肌梗塞的风险降低49%，且不利事件发生率低。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球药物释放型球囊导管市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 药物释放型球囊技术的应用日益广泛
    • 在冠状动脉和周边血管介入治疗的应用日益增多
    • 扩大无支架治疗方法方案
    • 拓展先进药包衣技术
    • 人们越来越重视预防血管再阻塞。

第五章 终端用户产业市场分析

  • 医院和诊所
  • 门诊手术中心
  • 导管检查室
  • 心臟专科医院
  • 血管治疗中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球药物释放型球囊导管市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球药物释放型球囊导管市场规模、比较及成长率分析
  • 全球药物释放型球囊导管市场表现：规模与成长，2020-2025年
  • 全球药物释放型球囊导管市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 冠状动脉疾病、週边血管疾病、药物释放型球囊导管
  • 药物
  • 紫杉醇、Sirolimus和其他药物
  • 按原料
  • 尼龙、聚氨酯及其他原料
  • 最终用户
  • 医院/诊所、门诊手术中心、导管检查室
  • 按类型细分：冠状动脉疾病
  • 用于冠状动脉的药物释放型球囊导管、用于冠状动脉支架内血管再阻塞的药物释放型球囊导管、用于冠状动脉小血管的药物释放型球囊导管
  • 按类型细分：週边血管疾病
  • 药物释放型球囊导管、股腘动脉药物释放型球囊导管、膝下（BTK）药物释放型球囊导管
  • 按类型细分：药物释放型球囊导管
  • 药物释放型血管成形术球囊导管

第十章 区域与国家分析

  • 全球药物释放型球囊导管市场：区域分析、预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球药物释放型球囊导管市场：依国家、表现及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 药物释放型球囊导管市场：竞争格局及市场占有率（2024年）
  • 药物释放型球囊导管市场：公司估值矩阵
  • 药物释放型球囊导管市场：公司概况
    • Abbott Laboratories
    • Medtronic PLC
    • Boston Scientific Corporation
    • B Braun Melsungen Aktiengesellschaft
    • Terumo Corporation

第37章：其他领先和创新企业

  • Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年药物释放型球囊导管市场：提供新机会的国家
  • 2030年药物释放型球囊导管市场：充满新机会的市场区隔
  • 2030年药物释放型球囊导管市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MDEBC01_G26Q1

A drug-eluting balloon catheter is a medical device utilized in the treatment of coronary artery disease through percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon that is coated with an anti-proliferative drug. During inflation, the drug is released into the vessel wall, aiming to prevent restenosis and reduce the risk of late thrombosis without the need for implanting a permanent foreign object.

The main types of drug-eluting balloon catheters include those designed for coronary artery disease and peripheral vascular disease. Coronary artery disease drug-eluting balloon catheters deliver antiproliferative drugs directly to the vessel wall using a lipophilic matrix, eliminating the need for a permanent structure such as a metal prosthesis or persistent polymer. Various drugs such as paclitaxel and sirolimus are used, and the catheters are made from raw materials such as nylon, polyurethane, and others. They find applications in hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

Tariffs are influencing the drug eluting balloon catheters market by increasing costs of imported pharmaceutical coatings, catheter polymers, precision tubing, and manufacturing equipment used in coronary and peripheral devices. Hospitals and catheterization laboratories in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on device exports. These tariffs are increasing device pricing and procurement complexity. However, they are also encouraging localized catheter manufacturing, regional sourcing of raw materials, and investment in domestic production capabilities.

The drug eluting balloons catheters market research report is one of a series of new reports from The Business Research Company that provides drug eluting balloons catheters market statistics, including drug eluting balloons catheters industry global market size, regional shares, competitors with a drug eluting balloons catheters market share, detailed drug eluting balloons catheters market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting balloons catheters industry. This drug eluting balloons catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.65 billion in 2025 to $1.86 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing prevalence of coronary artery disease, growing adoption of percutaneous coronary interventions, advancements in balloon catheter materials, clinical acceptance of paclitaxel-coated devices, expansion of interventional cardiology centers.

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.92 billion in 2030 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing demand for minimally invasive vascular therapies, rising adoption of sirolimus-based balloons, expansion of peripheral vascular disease treatments, growing investments in next-generation catheter technologies, increasing focus on long-term patient outcomes. Major trends in the forecast period include increasing adoption of drug-coated balloon technologies, rising use in coronary and peripheral interventions, growing preference for stent-free treatment options, expansion of advanced drug coating techniques, enhanced focus on restenosis prevention.

The increasing prevalence of peripheral and cardiovascular diseases is expected to drive the growth of the drug-eluting balloon catheter market in the coming years. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves the narrowing of arteries that reduces blood flow, primarily to the arms or legs. Drug-eluting balloon catheters are used in the treatment of coronary artery disease (CAD) and consist of semi-compliant angioplasty balloons coated with anti-proliferative agents that, upon contact with the vessel wall, exert anti-restenotic effects. For example, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted cardiovascular disease mortality rate increased to 233.3 deaths per 100,000 in 2024, representing a 4.0% year-on-year rise from 224.4 deaths per 100,000 in 2023. Consequently, the growing prevalence of peripheral and cardiovascular diseases is contributing to the expansion of the drug-eluting balloon catheter market.

Key players in the drug-eluting balloon catheter market are intensifying their efforts to develop next-generation products with advanced technologies to secure a competitive advantage. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based biomedical and biotechnology engineering firm, announced it had received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB). This product is the first drug-coated coronary balloon available in the U.S. specifically designed for treating in-stent restenosis (ISR), a condition where plaque or scar tissue obstructs a previously stented vessel. The AGENT DCB features a paclitaxel coating that provides a therapeutic dose to the vessel wall, effectively reducing ISR recurrence without the need for additional stents or radiation. Clinical trials demonstrated a 49% reduction in the risk of heart attack at the target site, along with low rates of adverse events.

In June 2023, Translumina Therapeutics Company acquired Blue Medical Devices BV for an undisclosed amount. This strategic acquisition aimed to integrate Blue Medical's unique drug application technology into Translumina's product lines, expanding offerings in neurovascular and peripheral interventions and enhancing drug coating capabilities. Blue Medical Devices BV is a Netherlands-based medical device company specializing in producing drug-eluting balloon catheters.

Major companies operating in the drug eluting balloons catheters market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

North America was the largest region in the drug eluting balloons catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug eluting balloons catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-eluting balloon catheter market consists of sales of everolimus and stellarex. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Balloons Catheters Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses drug eluting balloons catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting balloons catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug eluting balloons catheters market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Coronary Artery Disease; Peripheral Vascular Disease; Drug-Eluting Balloon Catheters
  • 2) By Drug: Paclitaxel; Sirolimus; Other Drugs
  • 3) By Raw Material: Nylon; Polyurethane; Other Raw Materials
  • 4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Catheterization Laboratories
  • Subsegments:
  • 1) By Coronary Artery Disease: Coronary Drug-Eluting Balloon Catheters; Coronary In-Stent Restenosis Drug-Eluting Balloon Catheters; Coronary Small-Vessel Drug-Eluting Balloon Catheters
  • 2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters; Femoro-Popliteal Drug-Eluting Balloon Catheters; Below-the-Knee (BTK) Drug-Eluting Balloon Catheters
  • 3) By Drug-Eluting Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B Braun Melsungen Aktiengesellschaft; Terumo Corporation; Cook Medical LLC; Lepu Medical Technology Co. Ltd.; Meril Life Sciences Pvt. Ltd.; MicroPort Scientific Corporation; BIOTRONIK SE & Co. KG; Acotec Scientific Co. Ltd.; Cordis Corporation; Biosensors International Group Ltd.; Zylox-Tonbridge Medical Technology Co. Ltd.; Hexacath Limited; Zhejiang Barty Medical Technology Co. Ltd.; Cardionovum GmbH; Nano Therapeutics Pvt. Ltd.; Tokai Medical Products Inc.; Opto Circuits Limited; Acrostak (Schweiz) AG; Concept Medical Inc.; Aachen Resonance GmbH; AR Baltic Medical UAB
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Drug Eluting Balloons Catheters Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Drug Eluting Balloons Catheters Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Drug Eluting Balloons Catheters Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Drug Eluting Balloons Catheters Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Drug-Coated Balloon Technologies
    • 4.2.2 Rising Use In Coronary And Peripheral Interventions
    • 4.2.3 Growing Preference For Stent-Free Treatment Options
    • 4.2.4 Expansion Of Advanced Drug Coating Techniques
    • 4.2.5 Enhanced Focus On Restenosis Prevention

5. Drug Eluting Balloons Catheters Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Catheterization Laboratories
  • 5.4 Cardiac Specialty Hospitals
  • 5.5 Vascular Treatment Centers

6. Drug Eluting Balloons Catheters Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Drug Eluting Balloons Catheters Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Drug Eluting Balloons Catheters PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Drug Eluting Balloons Catheters Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Drug Eluting Balloons Catheters Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Drug Eluting Balloons Catheters Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Drug Eluting Balloons Catheters Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Drug Eluting Balloons Catheters Market Segmentation

  • 9.1. Global Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Artery Disease, Peripheral Vascular Disease, Drug-Eluting Balloon Catheters
  • 9.2. Global Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Paclitaxel, Sirolimus, Other Drugs
  • 9.3. Global Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Nylon, Polyurethane, Other Raw Materials
  • 9.4. Global Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories
  • 9.5. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Coronary Artery Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Drug-Eluting Balloon Catheters, Coronary In-Stent Restenosis Drug-Eluting Balloon Catheters, Coronary Small-Vessel Drug-Eluting Balloon Catheters
  • 9.6. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Peripheral Vascular Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-Eluting Balloon Catheters, Femoro-Popliteal Drug-Eluting Balloon Catheters, Below-the-Knee (BTK) Drug-Eluting Balloon Catheters
  • 9.7. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Drug-Eluting Balloon Catheters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug-Eluting Angioplasty Balloon Catheters

10. Drug Eluting Balloons Catheters Market Regional And Country Analysis

  • 10.1. Global Drug Eluting Balloons Catheters Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Drug Eluting Balloons Catheters Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Drug Eluting Balloons Catheters Market

  • 11.1. Asia-Pacific Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Drug Eluting Balloons Catheters Market

  • 12.1. China Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Drug Eluting Balloons Catheters Market

  • 13.1. India Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Drug Eluting Balloons Catheters Market

  • 14.1. Japan Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Drug Eluting Balloons Catheters Market

  • 15.1. Australia Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Drug Eluting Balloons Catheters Market

  • 16.1. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Drug Eluting Balloons Catheters Market

  • 17.1. South Korea Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Drug Eluting Balloons Catheters Market

  • 18.1. Taiwan Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Drug Eluting Balloons Catheters Market

  • 19.1. South East Asia Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Drug Eluting Balloons Catheters Market

  • 20.1. Western Europe Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Drug Eluting Balloons Catheters Market

  • 21.1. UK Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Drug Eluting Balloons Catheters Market

  • 22.1. Germany Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Drug Eluting Balloons Catheters Market

  • 23.1. France Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Drug Eluting Balloons Catheters Market

  • 24.1. Italy Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Drug Eluting Balloons Catheters Market

  • 25.1. Spain Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Drug Eluting Balloons Catheters Market

  • 26.1. Eastern Europe Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Drug Eluting Balloons Catheters Market

  • 27.1. Russia Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Drug Eluting Balloons Catheters Market

  • 28.1. North America Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Drug Eluting Balloons Catheters Market

  • 29.1. USA Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Drug Eluting Balloons Catheters Market

  • 30.1. Canada Drug Eluting Balloons Catheters Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Drug Eluting Balloons Catheters Market

  • 31.1. South America Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Drug Eluting Balloons Catheters Market

  • 32.1. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Drug Eluting Balloons Catheters Market

  • 33.1. Middle East Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Drug Eluting Balloons Catheters Market

  • 34.1. Africa Drug Eluting Balloons Catheters Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Drug Eluting Balloons Catheters Market, Segmentation By Product, Segmentation By Drug, Segmentation By Raw Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Drug Eluting Balloons Catheters Market Regulatory and Investment Landscape

36. Drug Eluting Balloons Catheters Market Competitive Landscape And Company Profiles

  • 36.1. Drug Eluting Balloons Catheters Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Drug Eluting Balloons Catheters Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Drug Eluting Balloons Catheters Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. B Braun Melsungen Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Drug Eluting Balloons Catheters Market Other Major And Innovative Companies

  • Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited

38. Global Drug Eluting Balloons Catheters Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Drug Eluting Balloons Catheters Market

40. Drug Eluting Balloons Catheters Market High Potential Countries, Segments and Strategies

  • 40.1 Drug Eluting Balloons Catheters Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Drug Eluting Balloons Catheters Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Drug Eluting Balloons Catheters Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer